{"id":234832,"date":"2026-09-08T13:08:11","date_gmt":"2026-09-08T07:38:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=234832"},"modified":"2026-09-08T13:08:14","modified_gmt":"2026-09-08T07:38:14","slug":"albert-david-share-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/albert-david-share-bull-case-vs-bear-case-2026\/","title":{"rendered":"Albert David Share: Bull Case vs Bear Case for 2026"},"content":{"rendered":"
<\/div>\n

Albert David CMP Rs 859.95 on 8 Sep 2026. 52W High Rs 931.85, Low Rs 579.90. PE 21.65 vs sector 50.83. RSI 57.05.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Albert David bull case for 2026 points toward the stock retesting its 52 week high of Rs 931.85, built on the strengths discussed below. The Albert David bear case points toward a slide back near its 52 week low of Rs 579.90 if the risks play out instead. The stock currently trades at Rs 859.95, with a price to earnings multiple of 21.65 against an industry average of 50.83. The next two quarters of earnings and sector data will likely decide which case plays out.<\/p>\n<\/div>\n

The Albert David bull case is under the spotlight as investors weigh Albert David’s recent price action against its underlying fundamentals. The stock trades at Rs 859.95, against a 52 week high of Rs 931.85 and a 52 week low of Rs 579.90, leaving room for both the Albert David bull case and the Albert David bear case to find support in the data.<\/p>\n

Albert David operates in the Pharmaceuticals space, and its return on equity of -0.38 percent and debt to equity ratio of 0.08 form the backbone of the fundamental picture. This article lays out the full Albert David bull case and bear case, the data behind each scenario, and the catalysts that could tip the balance one way or the other.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n